Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
CLRB holding history
Cellectar Biosciences, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLRB overviewAll 13F holders of CLRBFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −24,900−100.0% | Sold out | Holders |
| Q3 2025 | 24,900 | $139.4K | <0.1% | +24,900 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −98,500−100.0% | Sold out | Holders |
| Q1 2024 | 98,500 | $392.0K | <0.1% | +98,500 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −21,690−100.0% | Sold out | Holders |
| Q3 2023 | 21,690 | $57.0K | <0.1% | −42,300−66.1% | Reduced | Holders |
| Q2 2023 | 63,990 | $125.0K | <0.1% | +6,589+11.5% | Added | Holders |
| Q1 2023 | 57,401 | $82.0K | <0.1% | +10,665+22.8% | Added | Holders |
| Q4 2022 | 46,736 | $80.0K | <0.1% | +29,046+164.2% | Added | Holders |
| Q3 2022 | 17,690 | $59.0K | <0.1% | +1,040+6.2% | AddedConverted for a 1-for-10 split | Holders |
| Q2 2022 | 166,500 | $67.0K | <0.1% | +39,700+31.3% | Added | Holders |
| Q1 2022 | 126,800 | $87.0K | <0.1% | +6,869+5.7% | Added | Holders |
| Q4 2021 | 119,931 | $80.0K | <0.1% | −327,143−73.2% | Reduced | Holders |
| Q3 2021 | 447,074 | $414.0K | <0.1% | −564,194−55.8% | Reduced | Holders |
| Q2 2021 | 1,011,268 | $1.20M | <0.1% | +118,711+13.3% | Added | Holders |
| Q1 2021 | 892,557 | $1.44M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.